40 Stocks Moving In Monday’s Mid-Day Session
Gainers
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.
Jefferies Initiates Coverage On Tabula Rasa HealthCare with Hold Rating, Announces Price Target of $13
Jefferies analyst Glen Santangelo initiates coverage on Tabula Rasa HealthCare (NASDAQ:TRHC) with a Hold rating and announces Price Target of $13.
Tabula Rasa HealthCare Announces 5-Year Contract Extension With Rocky Mountain PACE
Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year contract renewal with Rocky Mountain PACE (RMP), a
RBC Capital Maintains Outperform on Tabula Rasa HealthCare, Lowers Price Target to $23
RBC Capital analyst Sean Dodge maintains Tabula Rasa HealthCare (NASDAQ:TRHC) with a Outperform and lowers the price target from $70 to $23.
SVB Leerink Maintains Market Perform on Tabula Rasa HealthCare, Lowers Price Target to $23
SVB Leerink analyst Stephanie Davis maintains Tabula Rasa HealthCare (NASDAQ:TRHC) with a Market Perform and lowers the price target from $40 to $23.
64 Stocks Moving In Friday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.